SCHEMBL5458128

SCHEMBL5458128

CSc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ncccc3C)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.50
KMT2A Q03164 4/20 0.49
RAB9A P51151 7/20 0.49
NPC1 O15118 6/20 0.49
HTT P42858 1/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
KDM4E B2RXH2 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPT P10636 4/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 3/20 0.46
P2RY1 P47900 2/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.44
GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5470998 0.85 RAB9A (0.53) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5465363 0.84 RAB9A (0.52) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5451017 0.83 GFER (0.50) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5466986 0.83 P2RY1 (0.51) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5453308 0.82 GFER (0.53) TRPV1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL5465526 0.82 GLA (0.47) KMT2ARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL5473555 0.81 RAB9A (0.48) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5465407 0.81 TRPV1 (0.46) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5467111 0.80 MAPT (0.51) TRPV1KMT2ARAB9ANPC1HTT
SCHEMBL5467463 0.80 GFER (0.51) TRPV1RAB9ANPC1HTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 TRPV1 4674/4885KMT2A 1350/4885RAB9A 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.